5‐Alpha reductase inhibitor related litigation: A legal database review

Andrology ◽  
2021 ◽  
Author(s):  
Patrick Low ◽  
Kevin D. Li ◽  
Nizar Hakam ◽  
Alexander Bell ◽  
Behzad Abbasi ◽  
...  
Keyword(s):  
Reductase Inhibitor

186-OR: Safety and Tolerability of the Next Generation Aldose Reductase Inhibitor (ARI) AT-001 Supports Initiation of the Pivotal Trial in Diabetic Cardiomyopathy (DbCM)

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 186-OR
Author(s):  
RICCARDO PERFETTI ◽  
FRANCESCA C. LAWSON ◽  
JULIO ROSENSTOCK ◽  
JAMES JANUZZI ◽  
SHOSHANA SHENDELMAN ◽  
...  
Keyword(s):  
Aldose Reductase ◽  
Diabetic Cardiomyopathy ◽  
Reductase Inhibitor ◽  
Aldose Reductase Inhibitor ◽  
Pivotal Trial ◽  
Next Generation

462-P: AT-001, a Next Generation Aldose Reductase Inhibitor with Improved Selectivity and Specificity, Protects from Cellular Damage Associated with Hyperglycemia

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 462-P
Author(s):  
RICCARDO PERFETTI ◽  
GAUTHAM YEPURI ◽  
NOSIRUDEEN A. QUADRI ◽  
RAVICHANDRAN RAMASAMY ◽  
AMEEN F. GHANNAM ◽  
...  
Keyword(s):  
Aldose Reductase ◽  
Reductase Inhibitor ◽  
Aldose Reductase Inhibitor ◽  
Cellular Damage ◽  
Next Generation

Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235

Diabetes ◽  
1989 ◽  
Vol 38 (7) ◽  
pp. 832-838 ◽  
Author(s):  
H. Yasuda ◽  
M. Sonobe ◽  
M. Yamashita ◽  
M. Terada ◽  
I. Hatanaka ◽  
...  
Keyword(s):  
Diabetic Neuropathy ◽  
Aldose Reductase ◽  
Prostaglandin E1 ◽  
Reductase Inhibitor ◽  
Diabetic Rats ◽  
Aldose Reductase Inhibitor

Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor

Diabetes ◽  
1985 ◽  
Vol 34 (10) ◽  
pp. 970-972 ◽  
Author(s):  
D. R. Tomlinson ◽  
J. Townsend ◽  
P. Fretten
Keyword(s):  
Axonal Transport ◽  
Aldose Reductase ◽  
Reductase Inhibitor ◽  
Diabetic Rats ◽  
Aldose Reductase Inhibitor

Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month

Circulation ◽  
1997 ◽  
Vol 95 (5) ◽  
pp. 1126-1131 ◽  
Author(s):  
Gerard O'Driscoll ◽  
Danny Green ◽  
Roger R. Taylor
Keyword(s):  
Endothelial Function ◽  
Reductase Inhibitor ◽  
Coenzyme A ◽  
Coenzyme A Reductase

Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression

2019 ◽  
Vol 7 (7) ◽  
pp. 2889-2906 ◽  
Author(s):  
Venkatesh Teja Banala ◽  
Sandeep Urandur ◽  
Shweta Sharma ◽  
Madhu Sharma ◽  
Ravi P. Shukla ◽  
...  
Keyword(s):  
Aldose Reductase ◽  
Tumor Suppression ◽  
Reductase Inhibitor ◽  
Aldose Reductase Inhibitor ◽  
Down Regulation ◽  
Redox Responsive

Redox responsive epalrestat prodrug micelles facilitate synergistic concentrations of doxorubicin with an advantage of CD44 down-regulation and reduced cardiotoxicity.

Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells

2004 ◽  
Author(s):  
Takemi Otsuki ◽  
Haruko Sakaguchi ◽  
Tamayo Hatayama ◽  
Tomohiro Fujii ◽  
Takayuki Tsujioka ◽  
...  
Keyword(s):  
Reductase Inhibitor ◽  
Hmg Coa Reductase ◽  
Myeloma Cells ◽  
Hmg Coa Reductase Inhibitor ◽  
Coa Reductase ◽  
Human Myeloma Cells
Sign in / Sign up

Export Citation Format

Share Document